Open label pilot study to treat women with chronic urinary retention or voiding dysfunction due to a primary disorder of sphincter relaxation (Fowler's syndrome) with outpatient urethral sphincter injections of botulinum toxin A (BoNT-A)

Trial Profile

Open label pilot study to treat women with chronic urinary retention or voiding dysfunction due to a primary disorder of sphincter relaxation (Fowler's syndrome) with outpatient urethral sphincter injections of botulinum toxin A (BoNT-A)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Urinary retention
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2015 Results published in the BJU International
    • 16 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top